Detalhe da pesquisa
1.
Structure-guided optimization of 3-hydroxybenzoisoxazole derivatives as inhibitors of Aldo-keto reductase 1C3 (AKR1C3) to target prostate cancer.
Eur J Med Chem
; 268: 116193, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38364714